Picking Paths in CLL: Fresh Approaches and Tools to Individualize Treatment Across the Disease Spectrum

Gain in-depth knowledge and take-home strategies to improve outcomes and better individualize treatment for patients with CLL through a series of expert ClinicalThought commentaries, text modules with accompanying downloadable slides, and an interactive decision support tool.

Share

Program Content

Activities

CLL 1L Therapy
Key Considerations in Selecting Frontline Therapy for Patients With CLL/SLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 24, 2024

Expires: April 23, 2025

CLL/SLL: 2L Therapy
Key Considerations in Selecting Second-line Therapy for Patients With CLL/SLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 15, 2024

Expires: May 14, 2025

Activities

CLL Tool
Expert Guidance for the Treatment of CLL
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: August 20, 2024

Expires: August 19, 2025

Activities

Individualizing 1L CLL Therapy
Individualizing CLL Therapy: Frontline Treatment
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 30, 2024

Expires: August 29, 2025

Individualizing 2L+ CLL Therapy
Individualizing CLL Therapy: Second-Line Treatment and Beyond
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2024

Expires: August 15, 2025

Activities

Individualizing 1L CLL Therapy
Individualizing CLL Therapy: Frontline Treatment
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 30, 2024

Expires: August 29, 2025

Individualizing 2L+ CLL Therapy
Individualizing CLL Therapy: Second-Line Treatment and Beyond
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 13, 2024

Expires: September 12, 2025

Faculty

cover img faculity

Jeremy S Abramson, MD, MMSc

Director, Center for Lymphoma
Mass General Cancer Center
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Farrukh T. Awan, MD, MS, MBA

Professor of Internal Medicine
Director of Lymphoid Malignancies Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas

cover img faculity

Jennifer R. Brown, MD, PhD

Director, CLL Center & Institute Physician
Dana-Farber Cancer Institute
Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
Boston, Massachusetts 

cover img faculity

Nicole Lamanna, MD

Judy Horrigan Professor of Medicine
Director of the Chronic Lymphocytic Leukemia Program
Leukemia Service
Herbert Irving Comprehensive Cancer Center
Columbia University Medical Center/NewYork-Presbyterian
New York, New York

cover img faculity

Shuo Ma, MD, PhD

Professor of Medicine
Division of Hematology-Oncology
Department of Medicine
Feinberg School of Medicine
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, Illinois

cover img faculity

Sameer A Parikh, MBBS

Consultant, Division of Hematology
Chair, CLL Disease Team
Vice Chair, Lymphoid Malignancies Disease Group
Mayo Clinic Comprehensive Cancer Center
Associate Professor of Medicine
Assistant Professor of Oncology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Jennifer A. Woyach, MD

D. Warren Brown Professor of Leukemia Research
Division of Hematology
The Ohio State University
Columbus, Ohio

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with CLL Society.

Supporters

Supported by educational grants from AbbVie Inc.; AstraZeneca; Beigene, Ltd.; and Bristol Myers Squibb.

AbbVie Inc.

AstraZeneca

BeiGene, Ltd.

Bristol Myers Squibb

Partners

CLL Society

ProCE Banner